| Product Code: ETC12838378 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 South Korea Influenza B Market Overview |
3.1 South Korea Country Macro Economic Indicators |
3.2 South Korea Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 South Korea Influenza B Market - Industry Life Cycle |
3.4 South Korea Influenza B Market - Porter's Five Forces |
3.5 South Korea Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 South Korea Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 South Korea Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 South Korea Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 South Korea Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of influenza vaccination in South Korea |
4.2.2 Growing elderly population in South Korea, who are more susceptible to influenza B |
4.2.3 Government initiatives to promote influenza vaccination programs in the country |
4.3 Market Restraints |
4.3.1 Seasonality of influenza outbreaks leading to fluctuations in demand for vaccines |
4.3.2 Competition from other preventive healthcare measures and products |
4.3.3 Limited access to healthcare services in rural areas of South Korea |
5 South Korea Influenza B Market Trends |
6 South Korea Influenza B Market, By Types |
6.1 South Korea Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 South Korea Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 South Korea Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 South Korea Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 South Korea Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 South Korea Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 South Korea Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 South Korea Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 South Korea Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 South Korea Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 South Korea Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 South Korea Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 South Korea Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 South Korea Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 South Korea Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 South Korea Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 South Korea Influenza B Market Import-Export Trade Statistics |
7.1 South Korea Influenza B Market Export to Major Countries |
7.2 South Korea Influenza B Market Imports from Major Countries |
8 South Korea Influenza B Market Key Performance Indicators |
8.1 Percentage increase in influenza vaccination coverage rate among the elderly population |
8.2 Number of government-sponsored influenza vaccination campaigns conducted annually |
8.3 Rate of adherence to influenza vaccination recommendations among healthcare professionals. |
9 South Korea Influenza B Market - Opportunity Assessment |
9.1 South Korea Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 South Korea Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 South Korea Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 South Korea Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 South Korea Influenza B Market - Competitive Landscape |
10.1 South Korea Influenza B Market Revenue Share, By Companies, 2024 |
10.2 South Korea Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here